Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
This supplement was the priciest one on our list, at $1.33 per serving, but we feel that because it was also the supplement with the highest BCAA content on our list (at 8 g of BCAAs per serving), it's worth the additional cost
PMID: 41948476 Perez-Tilve D et al
Evaluation of alternative treatment strategies for bile acid malabsorption in inflammatory bowel disease patients: A network meta-analysis
US$ 24.96
US$ 21.58
US$ 24.89
US$ 23.75
US$ 20.76
US$ 29.53
US$ 21.94
US$ 24.38
